<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral microbleeds (MBs) may relate to amyloid in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We selected 26 probable <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) patients with MBs, 26 age- and sex-matched AD patients without MBs, 11 vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) patients, and 22 patients with subjective complaints </plain></SENT>
<SENT sid="2" pm="."><plain>We measured amyloid beta 1-42 (Aβ42) and 1-40 (Aβ40) in cerebrospinal fluid (CSF) and plasma, and blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) function using albumin ratios </plain></SENT>
<SENT sid="3" pm="."><plain>CSF Aβ42 was lowest in AD with MBs, whereas Aβ40 was selectively decreased in VaD </plain></SENT>
<SENT sid="4" pm="."><plain>In plasma, amyloid-beta was nonsignificantly elevated in VaD compared with controls </plain></SENT>
<SENT sid="5" pm="."><plain>Higher albumin ratios in VaD suggested blood-brain barrier dysfunction </plain></SENT>
<SENT sid="6" pm="."><plain>A MB pattern suggestive of <z:hpo ids='HP_0011970'>cerebral amyloid angiopathy</z:hpo> (CAA) related to lower CSF Aβ42, while a non-<z:hpo ids='HP_0011970'>cerebral amyloid angiopathy</z:hpo> specific MB distribution related to higher plasma Aβ40 </plain></SENT>
<SENT sid="7" pm="."><plain>Amyloid-beta is differentially implicated in AD with MBs and VaD </plain></SENT>
<SENT sid="8" pm="."><plain>MB distribution related to different amyloid profiles, supporting distinct etiologies </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that Aβ42 is retained in cerebrovasculature of AD patients with MBs, while in contrast, VaD patients may possibly drain amyloid </plain></SENT>
</text></document>